VWAV VWAV Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price at other companies

KopinKOPN

$3.21—

BTCSBTCS

$2.64+6.9%

Norwood FinancialNWFL

$7.56+0.3%

Alpha CognitionACOG

$5.90—

CTO

Citius Oncology, Inc.CTOR

$0.80—

MMT

Miluna Acquisition MMTX

$11.50—

Revenue$10.0M—

Operating income-$11.1M-7,634%

Net income-$12.9M-44,661%

EPS (diluted)-$0.66—

Cash & equivalents$14.3M+23,310%

Total equity$98.6M+32,583%

Total assets$135.7M—

Operating cash flow-$3.4M-1,952%

Market cap$110.62M+226%

Return on equity-52.8%—

Current ratio0.4×—

Reported directly by VWAV in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice.

The official record: VWAV’s 10-Q, filed May 20, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is VWAV's share based compensation arrangement by share based payment award fair value assumptions exercise price?: VWAV (VWAV) reported share based compensation arrangement by share based payment award fair value assumptions exercise price of $9.00 in Q1 2026.